RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 107 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $885,753 | +25.5% | 38,637 | -9.8% | 0.00% | +50.0% |
| Q2 2023 | $706,036 | -4.9% | 42,816 | +2.9% | 0.00% | 0.0% |
| Q1 2023 | $742,340 | -37.5% | 41,611 | +2.1% | 0.00% | -50.0% |
| Q4 2022 | $1,186,873 | +25.9% | 40,758 | +5.9% | 0.00% | +33.3% |
| Q3 2022 | $943,000 | +9.4% | 38,505 | -81.5% | 0.00% | +50.0% |
| Q2 2022 | $862,000 | -23.6% | 207,701 | +112.2% | 0.00% | 0.0% |
| Q1 2022 | $1,128,000 | +133.5% | 97,900 | +102.3% | 0.00% | +100.0% |
| Q4 2021 | $483,000 | -23.6% | 48,400 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $632,000 | -33.3% | 48,400 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $948,000 | -7.9% | 48,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,029,000 | -28.5% | 48,400 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $1,439,000 | +22.1% | 48,400 | -11.0% | 0.00% | 0.0% |
| Q3 2020 | $1,179,000 | +5.1% | 54,400 | +8.2% | 0.00% | 0.0% |
| Q2 2020 | $1,122,000 | +54.5% | 50,300 | +5.5% | 0.00% | +50.0% |
| Q1 2020 | $726,000 | -8.1% | 47,700 | +38.7% | 0.00% | 0.0% |
| Q4 2019 | $790,000 | +6.3% | 34,400 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $743,000 | +60.1% | 34,400 | +63.0% | 0.00% | +100.0% |
| Q2 2019 | $464,000 | -17.9% | 21,100 | +2.4% | 0.00% | -50.0% |
| Q1 2019 | $565,000 | +32.9% | 20,600 | +30.4% | 0.00% | +100.0% |
| Q4 2018 | $425,000 | +15.5% | 15,800 | +25.4% | 0.00% | 0.0% |
| Q3 2018 | $368,000 | -6.6% | 12,600 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $394,000 | – | 12,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |